Manuela Mollejo
Complejo Hospitalario Universitario de Toledo · 246 works · 9,671 citations · h-index 59
Top works
- Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms
- Primary Cutaneous CD4+ Small/Medium-sized Pleomorphic T-cell Lymphoma Expresses Follicular T-cell Markers
- Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria
- A Clinicopathological Study of 13 Cases
- Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma. A clinicopathological study of 13 cases.
- Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling
- Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients
- Analysis of the IgVH somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course
- Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype
- 7q31-32 Allelic Loss Is a Frequent Finding in Splenic Marginal Zone Lymphoma
- P53 protein expression in lymphomas and reactive lymphoid tissue
- Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome
- Progression to Large B-Cell Lymphoma in Splenic Marginal Zone Lymphoma
- Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis
- Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group
- Building an Outcome Predictor Model for Diffuse Large B-Cell Lymphoma
- EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation
- The molecular signature of mantle cell lymphoma reveals multiple signals favoring cell survival.
- Evaluation of the WHO criteria for the classification of patients with mastocytosis
- Expression of the NF‐κB targets BCL2 and BIRC5/Survivin characterizes small B‐cell and aggressive B‐cell lymphomas, respectively